By Vin Gurrieri ( July 17, 2015, 5:41 PM EDT) -- AstraZeneca AB told the Federal Circuit Thursday to affirm a ruling that Mylan Pharmaceuticals Inc. is subject to jurisdiction in Delaware in a suit over generic versions of two AstraZeneca diabetes drugs, saying the lower court was correct to allow the Hatch-Waxman case to proceed....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.